"MJNA's" HEMPMEDS CBD USED TO TREAT_AUTISM,_M.S.,_ALZHEIMER'S.
EXCERPT FROM PR:
SEATTLE, WA--(Marketwired - Mar 2, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s ( OTC PINK : MJNA ) Real Scientific Hemp Oil (RSHO™).
Medical Marijuana Inc.'s RSHO™ is a natural, full-spectrum cannabidiol (CBD) oil extracted from hemp plants grown in Northern Europe. The non-GMO hemp is cultivated without the use of herbicides, pesticides, or chemical fertilizers and the resulting CBD oil passes all federal requirements for open importation into the United States, as well as strict European Union regulations governing exports. Medical Marijuana Inc. recently announced that its HempMeds Brasil subsidiary secured approval for a prescription for RSHO to treat a patient with autism spectrum disorder. The move follows earlier approvals for the treatment of multiple sclerosis and Alzheimer's disease
, but marks the first time that Brazil's National Health Surveillance Agency (ANVISA) has granted a prescription of the company's RSHO™ for autism.
Mexican neurosurgeon Dr. Saul Garza also indicated that he is enrolling patients for a study on the effects of CBD on autism. Earlier, Dr. Garza concluded a study on Lennox-Gastaut epilepsy in Mexico with favorable results for the botanical CBD version that is allowed into Mexico (RSHO-X). These results will be published in the near future and presented at the International Epilepsy Congress in Barcelona, Spain on September 2-6, 2017.